Risk factors of venous thromboembolism in Thai patients

International Journal of Hematology

Volumn 86, Issue 5, 2007, Pages 397-402

  Angchaisuksiri, Pantep ^a   Atichartakarn, Vichai ^a   Aryurachai, Katcharin ^a   Archararit, Napaporn ^a   Rachakom, Buppa ^a   Atamasirikul, Kanlayanee ^a   Tiraganjana, Arjit ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Risk factors; Thai patients; Venous thromboembolism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTITHROMBIN DEFICIENCY; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC RISK; HUMAN; HYPERHOMOCYSTEINEMIA; IMMOBILIZATION; INJURY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RACE DIFFERENCE; RISK FACTOR; SURGICAL RISK; THAILAND; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CONTRACEPTIVES, ORAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR V; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASMS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN; RISK FACTORS; THAILAND; VENOUS THROMBOEMBOLISM;

EID: 38349022596     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02983995     Document Type: Article

References (49)

1. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692-699.
2. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117:19-25.
3. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991;151:933-938.
4. Atichartakarn V, Pathepchotiwong K, Keorochana S, Eurvilaichit C. Deep vein thrombosis after hip surgery among Thai. Arch Intern Med. 1988;148:1349-1353.
5. Talalak P. Thromboembolism in Thailand: incidence, coagulogram and its significance in therapeutic implication and prognosis. J Med Assoc Thai. 1976;59:6-11.
6. Chumnijarakit T, Poshyachinda V. Postoperative thrombosis in Thai women. Lancet. 1975;1:1357-1358.
7. Phornphibulaya P, Buranapong P, Ruksawin N, Viranuvatti J. The incidence of postoperative deep vein thrombosis in Thais. J Med Assoc Thai. 1984;67:377-381.
8. Resendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program. 2005:1-12.
9. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344:1222-1231.
10. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133-1134.
11. Herrmann FH, Koesling M, Schröder W, et al. Prevalence of factor V Leiden mutation in various populations. Genet Epidemiol. 1997;14:403-411.
12. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
13. Hillarp A, Zöller B, Svensson P, Dahlbäck B. The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost. 1997;78:990-992.
14. Angchaisuksiri P, Pingsuthiwong S, Aryuchai K, et al. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population. Am J Hematol. 2000;65:119-122.
15. 2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome. Clin Rheumatol. 2007;26:1663-1670.
16. Bauer KA. Approach to thrombosis. In: Loscalzo J, Schafer AI, eds. Thrombosis and Hemorrhage. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003:330-342.
17. Angchaisuksiri P, Pingsuthiwong S, Sura T, Aryuchai K, Busabaratana M, Atichartakarn V. Prevalence of the C677T methylenetetrahydrofolate reductase (MTHFR) mutation in Thai patients with deep vein thrombosis. Acta Haematol. 2000;103:191-196.
18. Lu Y, Zhao Y, Liu G, et al. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res. 2002;106:7-12.
19. Ho CH, Chau WK, Hsu HC, Gau JP, Chih CM. Prevalence of factor V Leiden in the Chinese population. Zhonghua Yi Xue Za Zhi. 1999;62:875-878.
20. Takamiya O, Ishida F, Kodaira H, Kitano K. APC-resistance and Mnl1 genotype (Gln 506) of coagulation factor V are rare in Japanese population. Thromb Haemost. 1995;74:996.
21. Bai C, Pan J, Li X. Factor V Leiden and PTG20210A gene mutation in patients with venous thrombosis and healthy blood donors [in Chinese]. Zhonghua Yi Xue Za Zhi. 1999;79:900-902.
22. Ho CH. Prevalence of prothrombin 20210A allele and methylenetetrahydrofolate reductase C677T genetic mutations in the Chinese population. Ann Hematol. 2000;79:239-242.
23. Jun ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol. 2006;28:111-116.
24. Miyata T, Kawasaki T, Fujimura H, Uchida K, Tsushima M, Kato H. The prothrombin gene G20210A mutation is not found among Japanese patients with deep vein thrombosis and healthy individuals. Blood Coagul Fibrinolysis. 1998;9:451-452.
25. Lin JS, Shen MC, Tsay W. The mutation at position 20210 in the 3′-untranslated region of the prothrombin gene is extremely rare in Taiwanese Chinese patients with venous thrombophilia. Thromb Haemost. 1998;80:343.
26. Lin JS, Shen MC, Tsai W, Lin B. The prevalence of C677T mutation in the methylenetetrahydrofolate reductase gene and its association with venous thrombophilia in Taiwanese Chinese. Thromb Res. 2000;97:89-94.
27. Mahasandana C, Suvatte V, Chuansumrit A, et al. Homozygous protein S deficiency in an infant with purpura fulminans. J Pediatr. 1990;117:750-753.
28. Chen TY, Su WC, Tsao CJ. Incidence of thrombophilia detected in southern Taiwanese patients with venous thrombosis. Ann Hematol. 2003;82:114-117.
29. Shen MC, Lin JS, Tsay W. Protein C and protein S deficiencies are the most important risk factors associated with thrombosis in Chinese venous thrombophilic patients in Taiwan. Thromb Res. 2000;99:447-452.
30. Ho CH, Chau WK, Hsu HC, Gau JP, Yu TJ. Causes of venous thrombosis in fifty Chinese patients. Am J Hematol. 2000;63:74-78.
31. Shen MC, Lin JS, Tsay W. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb Res. 1997;87:377-385.
32. Suehisa E, Nomura T, Kawasaki T, Kanakura Y. Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis. Blood Coagul Fibrinolysis. 2001;12:95-99.
33. Kinoshita S, Iida H, Inoue S, et al. Protein C and protein S gene mutations in Japanese deep vein thrombosis patients. Clin Biochem. 2005;38:908-915.
34. Zhao Y, Zhu T, Hua B, et al. Distribution of antithrombin, protein C, and protein S activities and prevalence of their deficiencies in the general Chinese healthy population. In: Program and abstracts of the 4th Asian-Pacific Congress on Thrombosis and Hemostasis. Asian-Pacific Society of Thrombosis and Hemostasis/International Society on Thrombosis and Hemostasis; September 21-23, 2006; Suzhou, China.
35. Akkawat B, Rojnuckarin P. Protein S deficiency is common in a healthy Thai population. J Med Assoc Thai. 2005;88(Suppl 4):S249-S254.
36. O'Donnell J, Tuddenham EG, Manning R, Kemball-Cook G, Johnson D, Laffan M. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to acute phase reaction. Thromb Haemost. 1997;77:825-828.
37. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med. 2000;342:696-701.
38. Coga A, Bernardi E, Prandoni P, et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med. 1994;154:164-168.
39. Markel A, Weich Y, Gaitini D. Doppler ultrasound in the diagnosis of venous thrombosis. Angiology. 1995;46:65-73.
40. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med. 1992;152:1660-1664.
41. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232:155-160.
42. Peng YY, Jeng JS, Shen MC, et al. Aetiologies and prognosis of Chinese patients with deep vein thrombosis of the lower extremities. QJM. 1998;91:681-686.
43. Lee HC, Liao WB, Bullard MJ, Hsu TS. Deep vein thrombosis in Taiwan. Jpn Heart J. 1996;37:891-896.
44. Bouillaud S. De l'Obliteration des veins et de son influence sur la formation des hydropisies partielles: consideration sur la hydropisies passive et general. Arch Gen Med. 1823;1:188-204.
45. Nordström M, Lindblad B, Anderson H, Bergqvist D, Kjellström T. Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ. 1994;308:891-894.
46. Blom JW, Doggen CJ, Osanto S, Resendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293:715-722.
47. Stein PD, Hull RD, Kayali F, Ghali WA, Alshab AK, Olson RE. Venous thromboembolism according to age: the impact of an aging population. Arch Intern Med. 2004;164:2260-2265.
48. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000;160:3415-3420.
49. Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population: the study of men born in 1913. Arch Intern Med. 1997;157:1665-1670.